PRP, Stem Cells and the Orthobiologic Hype in Sport

Few areas of sports medicine generate more hope and more confusion than orthobiologics, the umbrella term for injections that use the body’s own biological material to try to heal injuries. Platelet-rich plasma and stem-cell treatments are offered in clinics from Los Angeles to Dubai, often to elite athletes and increasingly to weekend warriors willing to pay out of pocket. The pitch is seductive: harness the body’s own repair machinery to fix a stubborn tendon or an arthritic joint without surgery. The evidence is far messier than the marketing, and separating what works from what merely sells is the whole job here.

What these treatments actually are

Platelet-rich plasma, or PRP, is made by drawing a patient’s blood, spinning it in a centrifuge to concentrate the platelets, and injecting that concentrate into an injured site. Platelets carry growth factors, so the theory is that a concentrated dose accelerates healing.

Stem-cell treatments are more varied and more loosely defined. In practice, most “stem cell” injections in sports clinics are not purified stem cells at all. They are bone marrow aspirate concentrate or fat-derived cell preparations that contain a mix of cells, only a fraction of which are mesenchymal stromal cells. The looseness of the term is part of the problem, because a clinic advertising “stem cells” may be injecting something quite different from what the patient imagines.

A key distinction matters throughout. PRP is not a stem-cell therapy. The two are often marketed together but rest on different biology and different, mostly weak, evidence.

Tendinopathy: the most studied use, and still uncertain

Chronic tendon problems, such as tennis elbow and patellar tendinopathy, are among the most common targets. Here the evidence is the most developed and still does not deliver a clean verdict. Some randomized trials and meta-analyses suggest PRP can modestly improve pain and function in certain tendinopathies, particularly lateral elbow tendinopathy, while others find no benefit over placebo or over simpler treatments like exercise rehabilitation.

The trials are plagued by inconsistency. PRP is not a standardized product, so preparations differ in platelet concentration, white-cell content and how they are injected, which makes pooling results difficult. The most defensible reading, reflected in reviews in the British Journal of Sports Medicine, is that PRP may help some tendon conditions somewhat, that it appears safe, and that progressive loading exercise remains the best-supported treatment for tendinopathy regardless.

Osteoarthritis: promising signals, no cure

For knee osteoarthritis, PRP has shown more encouraging results, with several trials reporting better pain and function compared with hyaluronic acid or saline injections over months. Even here the picture is not settled, because trial quality varies and the effect sizes are moderate rather than transformative. PRP does not regrow cartilage or reverse arthritis. At best it appears to buy symptom relief for a period.

Stem-cell injections for arthritis have weaker evidence still. Early-phase studies report safety and some symptom improvement, but rigorous, large, placebo-controlled trials showing they restore joint structure are lacking. Claims that these injections regenerate cartilage or make a joint “young again” run well ahead of the data.

The hype problem and the regulation gap

This is a field where promise and proof are routinely confused, and the financial incentives push in one direction. Many clinics sell these injections directly to patients for thousands of dollars, outside insurance and often outside rigorous oversight. Anti-doping rules add another layer, because some growth-factor treatments sit in a gray zone and athletes must check the World Anti-Doping Agency prohibited list before treatment.

Regulation has been slow to catch up. In the United States, the Food and Drug Administration has warned that many marketed stem-cell products are unapproved and that some have caused serious harm, including infections and, in a notorious case, blindness from injections into the eye. The agency’s position is that minimally manipulated tissue used for the same basic function may be exempt, but most expanded or cross-purpose cell products require approval the clinics do not have. Patients are, in effect, often buying experimental treatments marketed as established ones.

How to think about it as an athlete

A measured stance separates three categories. Established: PRP appears safe and may give modest, temporary benefit in selected tendinopathies and knee osteoarthritis. Promising but unproven: some stem-cell preparations may relieve symptoms, but evidence they heal tissue or change disease course is absent. Unproven and overhyped: claims of cartilage regeneration, anti-aging joints or guaranteed avoidance of surgery.

For an athlete weighing these options, the sensible path is to exhaust well-proven treatments first, exercise rehabilitation above all, and to treat orthobiologics as an adjunct with uncertain odds rather than a miracle. This is part of the same disciplined approach that supports extending athletic careers, where the basics usually outperform the expensive add-ons. The science may yet mature into something more definitive. It is not there today.

FAQ

Does PRP actually work for tendon injuries? The evidence is mixed. Some trials show modest improvement in pain and function for conditions like tennis elbow, while others find no benefit over placebo or exercise. PRP appears safe, but it is not a guaranteed fix, and loading exercise remains the best-supported treatment for tendinopathy.

Are stem-cell injections approved and safe? Most “stem cell” injections offered in sports clinics are not approved regenerative therapies and are not purified stem cells. Regulators including the FDA have warned that many such products are unproven and that some have caused serious harm. Early studies suggest possible symptom relief, but strong evidence that they heal tissue is lacking.

Will these injections let me avoid surgery? Sometimes they may delay or reduce symptoms enough to postpone surgery, but there is no reliable evidence they cure structural damage such as advanced arthritis or a full tendon tear. Promises of guaranteed surgery avoidance are not supported by the data.

Sources

1. Platelet-rich plasma in sports medicine: a critical review, British Journal of Sports Medicine
2. FDA warning on unapproved stem cell products, US Food and Drug Administration
3. Orthobiologics for osteoarthritis: consensus and evidence, American Academy of Orthopaedic Surgeons (OrthoInfo)
4. Prohibited list and therapeutic use, World Anti-Doping Agency
5. Platelet-rich plasma for knee osteoarthritis, Cochrane / Journal of the American Medical Association
6. Regenerative medicine in sport: hope and hype, Aspetar Sports Medicine Journal